Dubovsky S L, Thomas M
Department of Psychiatry, University of Colorado School of Medicine, Denver.
J Clin Psychiatry. 1995;56 Suppl 2:38-48.
The participation of serotonin (5-HT) in the regulation of diverse biological and psychological functions makes it possible for medications acting on 5-HT subsystems to play a role in the treatment of a growing number of psychiatric and medical disorders. The actions of new medications on the 5-HT reuptake mechanism are complemented by actions on the 5-HT receptors and on other neurotransmitter systems that may be effective in complex and treatment-resistant syndromes. New drugs acting on one or more of the seven major 5-HT receptor classes that have been identified thus far appear to be promising for the treatment of specific subtypes of psychiatric syndromes, from depression to anxiety to schizophrenia. A given serotonergic medication may be useful for more than one disorder because it acts on specific dimensions of psychobiological malfunction that characterize more than one disorder, dimensions that are mediated by more than one receptor.
血清素(5-羟色胺,5-HT)参与多种生物和心理功能的调节,这使得作用于5-HT子系统的药物能够在越来越多的精神和医学疾病的治疗中发挥作用。新型药物对5-HT再摄取机制的作用,辅之以对5-HT受体及其他神经递质系统的作用,这些作用在复杂和难治性综合征中可能有效。作用于迄今已确定的七种主要5-HT受体类别中的一种或多种的新药,对于治疗从抑郁症到焦虑症再到精神分裂症等特定亚型的精神综合征似乎很有前景。一种特定的血清素能药物可能对不止一种疾病有用,因为它作用于多种疾病所共有的心理生物功能障碍的特定方面,这些方面由不止一种受体介导。